Buy & Sell Valero Energy Corporation (VLO) – Valero Energy Corporation Price Today
Aura AI Summary
Key Stats
- $73.38BMarket Cap
- EnergySector
- -12.06%3M Drawdown
- $79.14BEnterprise Value
- 1.94%Dividend Yield
- 1% Buy | 99% SellTrading Activity
- 53 daysTypical Hold Time
Valero Energy Corporation (VLO) is currently valued at a market capitalization of $73.38B, with an enterprise value of $79.14B. Over the past 52 weeks, Valero Energy Corporation has traded between a low of $126.54 and a high of $254.32, highlighting its annual price range. Over the past three months, Valero Energy Corporation has recorded a drawdown of -12.06%, reflecting recent price volatility. Valero Energy Corporation offers a dividend yield of 1.94%, with the most recent dividend of $1.20 paid on 05 Feb 26. On average, investors hold Valero Energy Corporation for approximately 53 days, indicating typical investor behavior on the platform.
About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Most Recent News
Semiconductor recovery driven by supply constraints and pricing, not unit growth, led by memory chips for AI.
The semiconductor industry recovery is now led by memory chip pricing increases due to supply constraints rather than unit shipment growth. After a severe downturn in 2022, memory manufacturers cut capital expenditures and limited capacity expansion,...
Megan Holdings receives Nasdaq notice for falling below $1 minimum bid price, must regain compliance by Nov 2026.
Megan Holdings Limited announced it received a Nasdaq notification for not meeting the minimum bid price of $1 per share, with its shares trading below this threshold for 30 consecutive business days. The company has 180 days, until November 9, 2026,...
Absci insider buys shares amid financial challenges and positive clinical trial progress
A director at Absci purchased 37,453 shares, showing confidence despite the company's Q1 2026 revenue missing estimates by 90%. Absci reported a smaller-than-expected loss and progress in its ABS-201 clinical trial with positive safety data. The insi...